Physician profile
Jennifer L Gruenenfelder
NPI 1922063627
$75,633.33
in general payments reported to CMS, 2019-2025
14 companies · $4,555 in 2025
The $4,555 reported for 2025 was more than what 84% of Urogynecology and Reconstructive Pelvic Surgery (Urology) providers received nationally (typical 2025 total: $782).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $8,936 · 2021: $18K · 2022: $22K · 2023: $2,132 · 2024: $5,844 · 2025: $4,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,250 · Travel and Lodging: $3,137 · Food and Beverage: $2,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,250.00 |
| Travel and Lodging | $3,136.90 |
| Food and Beverage | $2,144.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $32,191.83 | 2019-2022 | |
| Abbvie INC. | $29,233.00 | 2019-2025 | |
| Axonics, INC. | $11,659.95 | 2020-2024 | Axonics, Bulkamid |
| Bluewind Medical | $1,383.15 | 2024-2025 | Revi |
| Coloplast Corp | $173.95 | 2020 | |
| Boston Scientific Corporation | $164.45 | 2024-2025 | Ams 800 Artificial Urinary Sphincter, Axonics |
| Urovant Sciences INC | $150.00 | 2022 | |
| Medtronic, INC. | $142.71 | 2021-2025 | Altaviva |
| Medtronic USA, INC. | $140.80 | 2019 | |
| Astellas Pharma US INC | $129.37 | 2019-2021 | |
| Intuitive Surgical, INC. | $108.85 | 2024 | |
| 180 Medical, INC. | $76.75 | 2023 | Gentlecath Glide |
| Pfizer INC. | $62.12 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $16.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Gruenenfelder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.